Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-25

Clinical Trial Update: Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates report on sulforaphane treatment for autism spectrum disorder in children, spanning Phase 1 and Phase 2 with completed status and posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulforaphane (sulforaphane)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Autism Spectrum Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-11-25